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ABSTRACT
Mapping sites within the genome that are hyper-
sensitive to digestion with DNaseI is an important
method for identifying DNA elements that regulate
transcription. The standard approach to locating
these DNaseI-hypersensitive sites (DHSs) has been
to use Southern blotting techniques, although
we, and others, have recently published alternative
methods using a range of technologies including
high-throughput sequencing and genomic array
tiling paths. In this article, we describe a novel pro-
tocol to use real-time PCR to map DHS. Advantages
of the technique reported here include the small cell
numbers required for each analysis, rapid, relatively
low-cost experiments with minimal need for
specialist equipment. Presented examples include
comparative DHS mapping of known TAL1/SCL
regulatory elements between human embryonic
stem cells and K562 cells.
INTRODUCTION
Mapping the location of DNaseI-hypersensitive sites
(DHSs) remains central to developing our understanding
of transcriptional regulation. Elements with a range of
transcriptional regulatory functions have been identiﬁed
initially as DHSs. These include transcriptional enhancers
(1,2) and repressors (3,4) as well as chromatin insulators
and barrier elements (5,6). A number of techniques have
been published recently that permit the mapping of DHSs
without the need for Southern blotting (7–13). These
include high-throughput sequencing of cloned DNA
libraries derived from DNaseI-digested chromatin (8,9),
and a number of diﬀerent approaches that use genomic
tiling path arrays to map DHSs (7,11,13). While these
approaches have the advantage of covering large genomic
regions with a limited number of experiments, they are
inherently costly and less applicable to the rapid
DHS mapping of speciﬁc genomic sites in a range of
cell types.
An alternative approach that does permit the targeted
semi-quantitative DHS mapping of speciﬁc loci has used
quantitative real-time PCR to map sites from digested
DNA (10). This technique depends on the quantiﬁcation
of relative loss of PCR signal observed when PCR primers
amplify across regions of digested DNA compared with
ampliﬁcation of undigested DNA. This approach has
been reported as showing good sensitivity, but a limitation
is the large number of PCR reactions required to quantify
the calculated loss of signal with signiﬁcant certainty.
In this article, we present an alternative method to identify
DHS using real-time PCR by adapting the protocol
we have used to map DHS using genomic tiling path
arrays (11). We have previously demonstrated the high
sensitivity and speciﬁcity of the basic protocol with regard
to identifying DHS across large genomic regions (11).
Here, we detail the laboratory protocol that permits
the rapid comparative mapping of known and candidate
DHS between diﬀerent cell types using real-time PCR.
As examples, we include comparative DHS mapping
of regulatory elements located across the extended TAL1
(T-cell acute lymphocytic leukaemia-1, also known as
SCL (stem cell leukaemia)) locus in human embryonic
stem (hES) cells and the leukaemia cell line K562.
RESULTS
Generatingalibrary ofDHSs
The basic protocol is outlined in Figure 1. Nuclei are
extracted from living cells, then digested on ice for 1h
with a range of DNaseI concentrations, as detailed in the
‘Materials and methods’ sections. Following RNaseA and
proteinaseK treatment, the DNA is extracted and run on
a 1% agarose gel to check for the size of digested DNA.
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thymocyte nuclei digested with 0, 40 and 120 units of
DNaseI. Maximal enrichment at DHS is usually observed
with samples that are not over-digested. In the experiment
shown, maximal enrichment at a known control DHS was
seen with 40 units DNaseI (real-time PCR quantiﬁcation
shown in Figure 2B). The DNA is then blunt-ended
using T4 polymerase (Figure 1B) and ligated with an
asymmetric double-stranded linker. After extraction,
DNA is ampliﬁed using a biotinylated linker-speciﬁc
primer and 35 thermal polymerase cycles, as detailed in
‘Materials and methods’ section. As the linker will ligate
to both ends of digested DNA, the ampliﬁcation will
represent a mix of primer extension and PCR, depending
on the length of DNA ampliﬁed. As has been previously
reasoned (13), one double strand of DNA in a region of
DNaseI hypersensitivity is more likely to be digested twice
within a short distance than non-hypersensitive DNA.
This will lead to the preferential ampliﬁcation of
DNA from regions of DHS. The ampliﬁed DNA is then
extracted using para-magnetic streptavidin beads, which
provides a DNA library representative of whole-genome
DHS. Agarose gel electrophoresis of the DNA recovered
from the beads conﬁrms that the vast majority of these
products are between 300 and 500 base pairs in length
(Figure 1B).
Real-time PCR quantification ofDNA
within theDHS library
Figure 2 documents the quantiﬁcation of speciﬁc DNA
sites from diﬀerent mouse-cell-derived DNA libraries.
Figure 2A shows the quantiﬁcation of material from two
primer sets, which are within (primer pair A) and 30
(primer pair B) to the mouse Stil promoter. The left-hand
panels of Figure 2A show the Sybr-green real-time
ﬂuorescence proﬁles using serial 5-fold dilutions of
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Figure 1. (A) Nuclei are isolated from cells, and aliquots are digested with a range of DNaseI as detailed in ‘Materials and methods’ section.
The DNA is extracted and run on 1% agarose gels using gel electrophoresis (right panel). With the example shown, the 40-units sample gave
maximal enrichment at a housekeeping promoter using the complete protocol. (B) The digested DNA is blunt-ended with T4 polymerase and ligated
to the LP21–25 linker as detailed in ‘Materials and methods’ section. Following ampliﬁcation with the biotinylated LP25 primer, the extracted
DNA template represents a library of whole-genome DHS. When samples of this library are visualised using gel electrophoresis (bottom panel),
the majority of products are between 300 and 500bp in size.
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and B. A calculated standard curve then permits the
quantiﬁcation of DNA from this sequence in library
samples. The right-hand panels of Figure 2A show
the quantiﬁcation of samples from 0 and 40 units
DNaseI-treated material using primers A and B. While
there is no diﬀerence in ampliﬁcation between the samples
using primer pair B, with primer pair A, the 40 units
DNaseI sample ampliﬁes  5.5 PCR cycles before the
0 units sample. This equates to greater than 40-fold
enrichment at the Stil promoter compared with no
observed enrichment downstream of the promoter.
Figure 2B shows the quantiﬁable diﬀerences in enrichment
at the porphobilinogen deaminase (Hmbs) promoter
between primary mouse thymocytes and the mouse
T-cell line BW5147. This representative primary mouse
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Figure 2. (A) The left-hand panels show the Sybr-green real-time PCR proﬁles (ﬂuorescence versus cycle number) of 5-fold dilutions of quantiﬁed
mouse genomic DNA standards for two primer pairs within (ppA) and 30 (ppB) of the Stil promoter. The right-hand panel shows that DNA template
derived from the 40 units DNaseI-treated sample ampliﬁed nearly six PCR cycles in advance of the 0 DNaseI-treated sample with ppA. No diﬀerence
in ampliﬁcation kinetics was seen between the 0 and 40 samples with ppB. (B) Quantiﬁcation of samples relative to genomic standards using primers
for the ‘housekeeping’ Hmbs promoter shows maximal enrichment with 40 units DNaseI treatment for primary mouse thymocytes (left panel)
compared with maximal enrichment with 120 units DNaseI for the mouse T-cell line, BW5147 (right panel).
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Figure 1A, which conﬁrms that with these cells, maximal
enrichment is observed from DNA that is not over-
digested. The comparison of the thymocytes with the
BW5147 cells illustrates another common ﬁnding that, in
our experience of primary cell experiments, maximal
enrichment is often obtained using lower amounts of
DNaseI compared with cell lines.
Comparison ofreal-time PCR DHSwithSouthern blotting
As the protocol generates template by primer extending
away from a DNaseI-digestion site, as well as PCR
ampliﬁcation between DNaseI-digestion sites, there is the
potential for the genomic size of the real-time DHS to be
larger than sites revealed by Southern blotting. There is
also potential for signal to be lost at the most ‘open’
stretch of DNA, due to over-digestion with DNaseI. These
issues are addressed in Figure 3. The upper panel shows
a Southern blot of the human STIL (SCL/TAL1 inter-
rupting locus) promoter in K562 cells. The BglII restricted
fragment is probed from the 30 end, as shown in the upper
panel. This reveals a central DHS  500bp wide, with
a suggestion of weaker hypersensitivity for a few hundred
base pairs 50 and 30 to the central region. The lower panel
shows real-time PCR data from K562 material using
10 primer sets, each generating an amplicon  120bp
long. This permits the quantiﬁcation of enrichments over
1200bp, centred around the STIL transcription start site.
The lower panel represents the mean SD enrichment
from three independent biological replicates from
K562 cells. The black bar denotes the location of the
‘core’ hypersensitive site as deﬁned by Southern blotting.
There is good correlation between the location of the DHS
between the two techniques. The 50 extension of enrich-
ment seen in the lower panel appears to reﬂect the weaker
50 extension seen in the Southern blot in the upper
panel. A dip in enrichment is observed in the lower panel
over the previously mapped transcription-factor-binding
sites (14), which may represent over-digestion of the
most accessible core region of the DHS.
Quantification of DHSacross theTAL1 locus
inhES andK562 cells
As examples of relative enrichments at diﬀerent regulatory
elements, we present a comparison of enrichments across
the extended TAL1 locus from human embryonic stem
(hES) cells and K562 cells in Figure 4B. Relative quanti-
ﬁcation of mRNA expression using real-time PCR shows
that both of these cell types express STIL, but only
K562 cells express TAL1 (Figure 4A). TAL1 expression
is critical to the establishment of haematopoiesis in
a developing embryo (15). Post embryogenesis, TAL1
expression is maintained in the non-lymphoid haemato-
poietic system, although in addition, expression is
observed in a range of non-haematopoietic tissues, includ-
ing endothelium and brain (16–18). Over the past 10 years,
we and others have dissected the regulatory elements
that direct the expression of TAL1 to diﬀerent tissues
(11,19–31). These include the 30 haematopoietic stem cell
enhancer (þ19) (24,30), the 50 endothelial-haematopoietic
enhancer ( 4) (31), the 30 erythroid enhancer (þ40
in mouse, þ50 in human) (28), and a number of neuronal
elements (25,26). The location of the STIL promoter has
been previously mapped (14), although no other STIL
regulatory elements have yet been identiﬁed.
Figure 4B shows the mean SD ratio (DNaseI-treated
enrichment/DNaseI-untreated enrichment) of quantitative
enrichments from two independent hES cell biological
replicates and two independent K562 biological replicates,
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Figure 3. The upper panel shows a Southern blot DHS map of the
human STIL promoter in K562 cells using a 30 probe (grey box labelled
‘P’) to analyse the BglII-restricted fragment (cut  4kb and þ4.2kb
relative to the STIL transcription start site). This revealed a core DHS
 500bp wide. The lower panel represents the mean SD real-time
PCR quantiﬁcation of enrichments from three biological replicates of
K562 material relative to known genomic standards, using 10 separate
primer sets that together amplify  1200bp centred around the STIL
transcription start site. The black bar represents the approximate
location of the DHS, as identiﬁed by the Southern blot experiment in
the upper panel. The real-time PCR ampliﬁcation proﬁle closely
represents the Southern blot proﬁle, although a central dip in real-time
PCR signal is observed over the site of transcription factor binding.
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in the ﬁgure. Primers indicated in red correspond to
known regulatory elements. The hES cell cultures were
maintained as detailed in methods. Both cell types show
signiﬁcant enrichment at the STIL promoter. Four control
regions were selected:  16kb, upstream of TAL1; þ5 and
þ22kb, within the TAL1 locus; þ70kb, downstream
of TAL1. These sequences were chosen as control regions
as they show limited homology between a number
of species (26) and were considered highly unlikely to
represent regulatory elements. All four regions showed
no enrichments between DNaseI-treated and -untreated
samples in either the hES cells or K562 cells. The
most striking diﬀerences between hES cells and K562
cells were found at the TAL1 regulatory elements. With
K562 cells, there is prominent enrichment at the TAL1
promoter 1a, and the  4, þ19 and þ50 enhancers. These
cells express high levels of TAL1 transcripts, and were
originally derived from a patient with blastic trans-
formation of chronic myeloid leukaemia. K562 cells are
relatively undiﬀerentiated, although they have a partial
erythroid phenotype. This potentially explains the marked
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Figure 4. (A) Quantitative reverse transcriptase PCR quantiﬁcation of STIL and TAL1 expression in hES and K562 cells. Expression was normalised
to b-actin and plotted as detailed in ‘Materials and methods’ section. Both cell types express STIL, but TAL1 transcripts were not detectable (U) in
hES cells. (B) Quantitative real-time PCR DNaseI proﬁles from hES and K562 cells using nine primer sets across the TAL1 locus. Primer set
numbers refer to approximate kilobases (kb) relative to the start of TAL1 exon 1a. Primer sets corresponding to known regulatory elements are
highlighted in red. Proﬁles represent the mean SD enrichment of material derived from two independent hES cell biological replicates, and two
independent K562 cell cultures. Each bar represents the mean ratio of enrichment obtained from DNaseI-treated samples versus DNaseI-untreated
samples for each cell type. With both cell types, no enrichment is seen at the four control sites ( 16, þ5, þ22, þ70kb). K562 cells show maximal
enrichments at the TAL1 regulatory elements and the STIL promoter, while hES cells show the highest enrichments at the STIL promoter and þ50
enhancer, with minimal enrichment at the other TAL1 regulatory elements.
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þ50 erythroid enhancer. This is similar to data obtained
from primary mouse erythroid cells (day 14.5 foetal liver),
which show the highest enrichments at the mouse
þ40 enhancer (homologous to the human þ50) (data
not shown). In contrast, the hES cells show markedly
reduced enrichment at the TAL1 regulatory elements
when compared with K562 cells. Although there is
enrichment at the þ50 enhancer, there is minimal
enrichment at the  4, promoter 1A and þ19 elements.
Reduced/absent accessibility of regulatory elements to
DNaseI digestion is consistent with the lack of expression
of TAL1 in hES cells (Figure 4A). As ES cells diﬀerentiate
to form embryoid bodies, expression of TAL1 is rapidly
switched on, appearing from day 3 of mouse ES cell
diﬀerentiation (32). The relative accessibility of the þ50
enhancer may reﬂect a poised chromatin state in hES cells,
which permits a rapid response to the changing transcrip-
tion factor environment that accompanies diﬀerentiation.
DISCUSSION
The development of techniques that permit the rapid
comparative mapping of DHS between diﬀerent cell
types will greatly facilitate the study of transcriptional
regulation in both normal and diseased cells. Recently
published high-throughput techniques that map DHS
sites using high-throughput sequencing (8,9) and genomic
array tiling paths (7,11,13) have clear advantages of scale
over more targeted approaches. Major disadvantages
of these approaches include cost and lack of focus.
This makes them less suitable for many laboratories that
want to assess the chromatin accessibility of a number
of deﬁned or presumed regulatory elements in a range
of cell types. A real-time-PCR-based approach to DHS
mapping has, therefore, a number of potential advantages
for researchers interested in speciﬁc regulatory questions
at deﬁned loci. Real-time PCR is relatively inexpensive
compared with the large-scale techniques, and permits
a rapid, focused DHS analysis of deﬁned regions of DNA
from multiple cell types. It also provides ﬂexibility, as
any genomic region can be analysed from the DNA library
derived from the DNaseI-treated samples by designing
further real-time PCR primer sets.
We have previously shown that our basic technique
for amplifying a library of DHS generates a template
representative of known DHS with excellent sensitivity
and speciﬁcity (11). Although the experiments presented
in this paper were each performed using 5 million
cells/digestion condition, we have obtained reproducible
data using 5-fold fewer cells as starting material.
We feel our technique can deliver acceptable speciﬁcity
and sensitivity for DHS mapping with small numbers of
cells, and will therefore be of use to those researchers
working with limited numbers of primary cells. An
alternative approach using real-time PCR to deﬁne DHS
has been previously published (10). The two approaches
diﬀer in that Dorscher et al. quantify the DHS through the
loss of PCR signal obtained from DHS when DNA
is digested, whereas our approach uses real-time PCR to
quantify a gain of signal observed from DHS. Dorscher
et al. report excellent sensitivity using their approach to
map DHS. However, the technique depends on large
numbers of comparative quantitative real-time PCR
reactions across a region in both digested and undigested
material, in order to quantify the loss of enrichment. One
advantage of our technique published here is that data can
be obtained using far fewer quantitative PCR reactions.
The technique is highly reproducible, with relatively little
variation in quantiﬁable enrichments observed between
diﬀerent biological replicates. Moreover, we demonstrate
tissue speciﬁcity, with variable enrichment at known
regulatory elements between diﬀerent cell types.
The technique published here permits the rapid
comparative analysis of DHS between diﬀerent cell
types from relatively small numbers of cells. It will have
potential use for researchers across a broad spectrum
of biology for the study of transcriptional regulation in
both healthy and diseased tissues.
MATERIALS AND METHODS
Cell culture
Cell lines were maintained in culture as previously
described (11). Care was taken to ensure maximum
viability of cells when taken for experiments. The primary
thymocytes used for Figure 2 were prepared by gentle
physical disassociation of a whole thymus gland into PBS
supplemented with 2% FCS. Cells were ﬁltered to ensure
that a single-cell suspension was taken forward for nuclei
isolation. Human embryonic stem cells (hES) were grown
in chemically deﬁned media in the presence of Activin
and FGF2, as detailed previously (33). In these conditions,
hES cells remain homogenously undiﬀerentiated.
Nuclei preparation
Up to 3 10
7 cells were washed in ice-cold PBS and
resuspended in 2ml of ice-cold cell lysis buﬀer [300mM
sucrose, 10mM Tris pH 7.4, 15mM NaCl, 5mM MgCl,
0.1mM EGTA, 60mM KCl, 0.2% NP-40, 0.5mM DTT,
0.5mM spermidine, 1  protease inhibitor (complete,
Roche)]. After 5min, the lysed cells were spun at 500g
for 5min at 48C with brakes oﬀ. After careful removal of
supernatant, the nuclei were gently resuspended in 200ml
of ice-cold reaction buﬀer (20ml1 0   DNaseI buﬀer, 4ml
glycerol, 176ml water) using pipette tips with cut oﬀ ends.
The nuclei were spun again at 500g for 5min at 48C and,
following supernatant removal, were resuspended in 30ml
of reaction buﬀer per DNaseI condition. For example,
if 2 10
7 cells were taken to look at four diﬀerent
conditions (e.g. 0, 20, 60, 120 units DNaseI), the nuclei
were resuspended in 120ml of reaction buﬀer. Separate
30ml aliquots were then taken and gently mixed with 70ml
of DNaseI mix (see Table 1) on ice. This made a ﬁnal
digestion volume of 100ml for each sample, which was
left to incubate for 1h on ice in the cold room.
After 1h, 700ml of nuclei lysis buﬀer (100mM tris HCL
pH 8, 5mM EDTA pH 8, 200mM NaCl, 0.2% SDS) was
added to each sample with 50mg proteinase K. Following
gentle mixing with inversion, the lysed samples were
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then added to each sample and further incubated at 378C
for 30min. DNA was then extracted using standard
phenol–chloroform techniques. Care was taken to use
cut-oﬀ tips and very gentle pipetting to reduce non-speciﬁc
DNA sheering. Following precipitation, DNA was
resuspended in 200ml of 0.1 TE and quantiﬁed using
spectophotometry. Samples (1mg) were analysed using
gel-electrophoresis, as shown in Figure 1A.
DNA library preparation
Following quantiﬁcation, 7.5mg of DNA was taken for
each sample condition. This was blunt-ended using
T4 polymerase (10ml1 0   buﬀer, 0.5ml 25mM dNTP,
3ml BSA, 1ml T4 polymerase (3U/ml NE Biolabs), 85.5ml
of water/DNA in 0.1 TE). The samples were mixed gently
on ice, then put at 128C for 16min. The reaction was
stopped with excess EDTA (4ml 0.5M) followed by
758C for 10min. The DNA was further extracted using
phenol–chloroform and precipitated with ethanol.
Glycogen carrier (5mg) was used at this stage, and the
pellet resuspended in 80ml water.
The blunt-ended DNA was then ligated to the LP21–25
linker. A stock of linker was prepared by mixing 80ml
LP21 (100mM: GAATTCAGATCTCCCGGGTCA) with
80ml LP25 (100mM: GCGGTGACCCGGGAGATCTG
AATTC) and 240ml water. The mix was then placed on a
958C hot block and the power supply turned oﬀ. When the
block had cooled to room temperature, the LP21–25
linker was aliquoted and frozen. The 80ml DNA sample
was split into two samples for ligation (5ml1 0   buﬀer,
3ml LP21–25 linker, 3ml ligase (NE biolabs 400U/ml and
39ml DNA). This was mixed well with a pipette and left
at 168C overnight.
Following ligation, the DNA was precipitated with
ethanol, and resuspended in 42ml water. The sample was
ampliﬁed using Vent exo-polymerase and a biotinylated
LP25 primer. The mix (5ml ThermoPol 10  buﬀer, 0.5ml
B-LP25 (200mM), 2ml Vent exo-(NE Biolabs 2U/ml), 1ml
dNTP (25mM) and 41.5ml DNA) was ampliﬁed with the
following thermal cycle: (958C 3min, 958C3 0s ,6 1 8C3 0s ,
728C3 0s ) 35 cycles.
Following ampliﬁcation, the biotinylated products were
extracted using Dynal streptavidin beads. For each
sample, 30ml of beads (Dyabeads M-270; Dynal biotech)
were washed twice in 2  binding buﬀer (10mM Tris HCL
pH7.5, 1mM EDTA, 2M NaCl) using a magnet, and then
resuspended in 50mlo f2   binding buﬀer/sample. Each
post ampliﬁcation sample (50ml) was then mixed with
50ml of resuspended beads and incubated at room tem-
perature on a rotator for 1h. After binding, the samples
were washed twice with 2  binding buﬀer, then once with
1  TE. After the last wash, each sample was resuspended
in 30ml 0.1 TE. The paired samples that were split before
ligation were then pooled, making a 60ml ﬁnal aliquot.
This was heated at 958C for 10min to free the DNA from
the beads, and then stored at 48C.
Real-time PCRquantification
We have used Stratagene Brilliant SYBR Green QPCR
Master Mix as our standard kit for quantiﬁcation of
genomic controls and samples. We have used a range of
primer sets. The HMBS primers are: human—Forward;
ATGCTGCCTATTTCAAGGTTGT, Reverse; GAATT
GGAACATTGCGACAGT, and mouse—Forward;
CGGAGTCATGTCCGGTAAC, Reverse; CGACCAA
TAGACGACGAGAA. Primers from the TAL1 locus
(human and mouse) are available on request.
Ampliﬁcation conditions and PCR mixes were as
recommended by Stratagene. Genomic standard curves
were calculated for each primer using serial 5-fold
dilutions from 50ng genomic DNA/PCR reaction. For
each sample PCR, a 45ml stock was made using 1.3ml
of sample DNAþ43.7ml water. This stock was used as
5ml per real-time PCR reaction, and following ampli-
ﬁcation, quantiﬁed relative to the genomic DNA standard
curve, for each primer set. The quantiﬁcations shown
in Figure 3 represent the absolute quantiﬁcation of DNA
at each primer set for the 5ml PCR sample.
The mRNA expression levels of TAL1 and STIL in
Figure 4A were normalised relative to b-actin and plotted
relative to mRNA expression from normal human donor
CD34þcells, as described previously (11).
ACKNOWLEDGEMENTS
GAF is a Leukaemia Research Fund (LRF) Bennett
Fellow. Work in BG’s laboratory is supported by the LRF
and ARG’s laboratory is supported by the LRF and the
Wellcome Trust. Funding to pay the open Access
publication charge was provided by the Wellcome Trust.
Conﬂict of interest statement. None declared.
REFERENCES
1. Follows,G.A., Tagoh,H., Lefevre,P., Hodge,D., Morgan,G.J. and
Bonifer,C. (2003) Epigenetic consequences of AML1-ETO action at
the human c-FMS locus. EMBO J., 22, 2798–2809.
2. Vyas,P., Vickers,M.A., Simmons,D.L., Ayyub,H., Craddock,C.F.
and Higgs,D.R. (1992) Cis-acting sequences regulating expression of
the human alpha-globin cluster lie within constitutively open
chromatin. Cell, 69, 781–793.
3. Sawada,S., Scarborough,J.D., Killeen,N. and Littman,D.R. (1994)
A lineage-speciﬁc transcriptional silencer regulates CD4 gene
expression during T lymphocyte development. Cell, 77, 917–929.
4. Ansel,K.M., Greenwald,R.J., Agarwal,S., Bassing,C.H.,
Monticelli,S., Interlandi,J., Djuretic,I.M., Lee,D.U., Sharpe,A.H.
et al. (2004) Deletion of a conserved Il4 silencer impairs T helper
type 1-mediated immunity. Nat. Immunol., 5, 1251–1259.
5. Mutskov,V.J., Farrell,C.M., Wade,P.A., Wolﬀe,A.P. and
Felsenfeld,G. (2002) The barrier function of an insulator couples
high histone acetylation levels with speciﬁc protection of promoter
DNA from methylation. Genes Dev., 16, 1540–1554.
Table 1. DNaseI mixes of 70ml aliquots were prepared as detailed
DNaseI condition (units) 0 20 60 120
10  DNaseI buﬀer (ml ) 7777
DNaseI (2U/ml) (Ambion) (ml ) 01 03 06 0
Water (ml) 63 53 33 3
The resuspended nuclei were added as 30ml aliquots to make a ﬁnal
digestion volume of 100ml.
PAGE 7 OF 8 Nucleic Acids Research, 2007, Vol. 35, No. 8 e566. Chung,J.H., Whiteley,M. and Felsenfeld,G. (1993) A 50 element of
the chicken beta-globin domain serves as an insulator in human
erythroid cells and protects against position eﬀect in Drosophila.
Cell, 74, 505–514.
7. Crawford,G.E., Davis,S., Scacheri,P.C., Renaud,G., Halawi,M.J.,
Erdos,M.R., Green,R., Meltzer,P.S., Wolfsberg,T.G. et al. (2006)
DNase-chip: a high-resolution method to identify DNase I
hypersensitive sites using tiled microarrays. Nat. Methods, 3,
503–509.
8. Crawford,G.E., Holt,I.E., Mullikin,J.C., Tai,D., Blakesley,R.,
Bouﬀard,G., Young,A., Masiello,C., Green,E.D. et al. (2004)
Identifying gene regulatory elements by genome-wide recovery
of DNase hypersensitive sites. Proc. Natl. Acad. Sci. USA, 101,
992–997.
9. Crawford,G.E., Holt,I.E., Whittle,J., Webb,B.D., Tai,D., Davis,S.,
Margulies,E.H., Chen,Y., Bernat,J.A. et al. (2006) Genome-
wide mapping of DNase hypersensitive sites using massively
parallel signature sequencing (MPSS). Genome Res., 16,
123–131.
10. Dorschner,M.O., Hawrylycz,M., Humbert,R., Wallace,J.C.,
Shafer,A., Kawamoto,J., Mack,J., Hall,R., Goldy,J. et al. (2004)
High-throughput localization of functional elements by quantitative
chromatin proﬁling. Nat. Methods, 1, 219–225.
11. Follows,G.A., Dhami,P., Gottgens,B., Bruce,A.W., Campbell,P.J.,
Dillon,S.C., Smith,A.M., Koch,C., Donaldson,I.J. et al. (2006)
Identifying gene regulatory elements by genomic
microarray mapping of DNaseI hypersensitive sites. Genome Res.,
16, 1310–1319.
12. Sabo,P.J., Humbert,R., Hawrylycz,M., Wallace,J.C.,
Dorschner,M.O., McArthur,M. and Stamatoyannopoulos,J.A.
(2004) Genome-wide identiﬁcation of DNaseI hypersensitive sites
using active chromatin sequence libraries. Proc. Natl. Acad. Sci.
USA, 101, 4537–4542.
13. Sabo,P.J., Kuehn,M.S., Thurman,R., Johnson,B.E., Johnson,E.M.,
Cao,H., Yu,M., Rosenzweig,E., Goldy,J. et al. (2006) Genome-scale
mapping of DNase I sensitivity in vivo using tiling DNA
microarrays. Nat. Methods, 3, 511–518.
14. Aplan,P.D., Lombardi,D.P. and Kirsch,I.R. (1991) Structural
characterization of SIL, a gene frequently disrupted in T-cell acute
lymphoblastic leukemia. Mol. Cell. Biol., 11, 5462–5469.
15. Robb,L., Lyons,I., Li,R., Hartley,L., Kontgen,F., Harvey,R.P.,
Metcalf,D. and Begley,C.G. (1995) Absence of yolk sac hemato-
poiesis from mice with a targeted disruption of the scl gene.
Proc. Natl. Acad. Sci. USA, 92, 7075–7079.
16. van Eekelen,J.A., Bradley,C.K., Gothert,J.R., Robb,L.,
Elefanty,A.G., Begley,C.G. and Harvey,A.R. (2003) Expression
pattern of the stem cell leukaemia gene in the CNS of the
embryonic and adult mouse. Neuroscience, 122, 421–436.
17. Drake,C.J., Brandt,S.J., Trusk,T.C. and Little,C.D. (1997) TAL1/
SCL is expressed in endothelial progenitor cells/angioblasts and
deﬁnes a dorsal-to-ventral gradient of vasculogenesis. Dev. Biol.,
192, 17–30.
18. Gering,M., Rodaway,A.R., Gottgens,B., Patient,R.K. and
Green,A.R. (1998) The SCL gene speciﬁes haemangioblast devel-
opment from early mesoderm. EMBO J., 17, 4029–4045.
19. Begley,C.G., Robb,L., Rockman,S., Visvader,J., Bockamp,E.O.,
Chan,Y.S. and Green,A.R. (1994) Structure of the gene encoding
the murine SCL protein. Gene, 138, 93–99.
20. Bockamp,E.O., McLaughlin,F., Murrell,A. and Green,A.R. (1994)
Transcription factors and the regulation of haemopoiesis: lessons
from GATA and SCL proteins. Bioessays, 16, 481–488.
21. Bockamp,E.O., McLaughlin,F., Murrell,A.M., Gottgens,B.,
Robb,L., Begley,C.G. and Green,A.R. (1995) Lineage-restricted
regulation of the murine SCL/TAL-1 promoter. Blood, 86,
1502–1514.
22. Bockamp,E.O., McLaughlin,F., Gottgens,B., Murrell,A.M.,
Elefanty,A.G. and Green,A.R. (1997) Distinct mechanisms direct
SCL/tal-1 expression in erythroid cells and CD34 positive primitive
myeloid cells. J. Biol. Chem., 272, 8781–8790.
23. Gottgens,B., McLaughlin,F., Bockamp,E.O., Fordham,J.L.,
Begley,C.G., Kosmopoulos,K., Elefanty,A.G. and Green,A.R.
(1997) Transcription of the SCL gene in erythroid and CD34
positive primitive myeloid cells is controlled by a complex
network of lineage-restricted chromatin-dependent and chromatin-
independent regulatory elements. Oncogene, 15, 2419–2428.
24. Sanchez,M., Gottgens,B., Sinclair,A.M., Stanley,M., Begley,C.G.,
Hunter,S. and Green,A.R. (1999) An SCL 30 enhancer targets
developing endothelium together with embryonic and adult
haematopoietic progenitors. Development, 126, 3891–3904.
25. Sinclair,A.M., Gottgens,B., Barton,L.M., Stanley,M.L.,
Pardanaud,L., Klaine,M., Gering,M., Bahn,S., Sanchez,M. et al.
(1999) Distinct 50 SCL enhancers direct transcription to developing
brain, spinal cord, and endothelium: neural expression is mediated
by GATA factor binding sites. Dev. Biol., 209, 128–142.
26. Gottgens,B., Barton,L.M., Gilbert,J.G., Bench,A.J., Sanchez,M.J.,
Bahn,S., Mistry,S., Grafham,D., McMurray,A. et al. (2000)
Analysis of vertebrate SCL loci identiﬁes conserved enhancers.
Nat. Biotechnol., 18, 181–186.
27. Gottgens,B., Barton,L.M., Chapman,M.A., Sinclair,A.M.,
Knudsen,B., Grafham,D., Gilbert,J.G., Rogers,J., Bentley,D.R.
et al. (2002) Transcriptional regulation of the stem cell leukemia
gene (SCL)-comparative analysis of ﬁve vertebrate SCL loci.
Genome Res., 12, 749–759.
28. Delabesse,E., Ogilvy,S., Chapman,M.A., Piltz,S.G., Gottgens,B.
and Green,A.R. (2005) Transcriptional regulation of the SCL locus:
identiﬁcation of an enhancer that targets the primitive erythroid
lineage in vivo. Mol. Cell. Biol., 25, 5215–5225.
29. Silberstein,L., Sanchez,M.J., Socolovsky,M., Liu,Y., Hoﬀman,G.,
Kinston,S., Piltz,S., Bowen,M., Gambardella,L. et al. (2005)
Transgenic analysis of the SCLþ19 stem cell enhancer in adult and
embryonic haematopoietic and endothelial cells. Stem Cells.
30. Gottgens,B., Nastos,A., Kinston,S., Piltz,S., Delabesse,E.C.,
Stanley,M., Sanchez,M.J., Ciau-Uitz,A., Patient,R. et al. (2002)
Establishing the transcriptional programme for blood: the SCL stem
cell enhancer is regulated by a multiprotein complex containing Ets
and GATA factors. EMBO J., 21, 3039–3050.
31. Gottgens,B., Broccardo,C., Sanchez,M.J., Deveaux,S., Murphy,G.,
Gothert,J.R., Kotsopoulou,E., Kinston,S., Delaney,L. et al. (2004)
The sclþ18/19 stem cell enhancer is not required for hematopoiesis:
identiﬁcation of a 50 bifunctional hematopoietic-endothelial enhan-
cer bound by Fli-1 and Elf-1. Mol. Cell. Biol., 24, 1870–1883.
32. Chung,Y.S., Zhang,W.J., Arentson,E., Kingsley,P.D., Palis,J. and
Choi,K. (2002) Lineage analysis of the hemangioblast as deﬁned by
FLK1 and SCL expression. Development, 129, 5511–5520.
33. Vallier,L., Alexander,M. and Pedersen,R.A. (2005) Activin/Nodal
and FGF pathways cooperate to maintain pluripotency of human
embryonic stem cells. J. Cell Sci., 118, 4495–4509.
e56 Nucleic Acids Research, 2007, Vol. 35, No. 8 PAGE 8 OF8